Adaptimmune Therapeutics PLC (ADAP)
0.5856
+0.02
(+3.15%)
USD |
NASDAQ |
Dec 27, 16:00
0.5856
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Free Cash Flow: -56.05M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals PLC | -11.12M |
| Autolus Therapeutics PLC | -205.61M |
| TC BioPharm (Holdings) PLC | -15.38M |
| Verona Pharma PLC | -103.81M |
| NuCana PLC | -15.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.45M |
| Cash from Investing (Quarterly) | -66.02M |
| Cash from Financing (Quarterly) | 25.00M |
| Free Cash Flow Per Share (Quarterly) | -0.2146 |
| Free Cash Flow to Equity (Quarterly) | -79.80M |
| Free Cash Flow to Firm (Quarterly) | -54.89M |
| Free Cash Flow Yield | -38.87% |